Vancouver, BC, November 24, 2023--Ondine Biomedical's Steriwave nasal photodisinfection technology has been shortlisted in the biomedical category of the 2024 international society for optics and photonics SPIE Prism Awards.
Vancouver, BC, October 31, 2023--Vancouver-based life sciences company Ondine Biomedical anounced that it's Steriwave nasal photodisinfection for the prevention of healthcare-associated infections (HAIs) is now available in hospitals across Canada.
Vancouver, BC, April 28, 2023--Ondine Biomedical Inc. annonced that it recently presented detailed results from its US Phase 2 BENEFIT-aPDT clinical trial to the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Copenhagen, Denmark.
Vancouver, BC, March 6, 2023--Ondine Biomedical announced that one of Canada's top research hospitals, The Ottawa Hospital, has presented results from its 2022 quality improvement study into patient outcomes after spinal surgery when using the company's nasal photodisinfection for the prevention of surgical site infections ('SSIs').
Vancouver, BC, November 10, 2022--Research presented at the PDT-PDD Conference in Nancy, France showed that a large food processing plant in Manitoba, Canada, was able to reduce the rate of COVID-19 amongst its employees following the use of Vancouver-based Ondine Biomedical's nasal photodisinfection.
Vancouver, BC, October 28, 2022--Ondine Biomedical, Inc. (LON:OBI): announced that new research presented at the Infection Prevention Society Conference in Bournemouth, UK, shows that adding Steriwave nasal photodisinfection to a presurgical bundle including 2% chlorhexidine (CHG) body wash cloths reduced post-operative surgical site infections (SSIs) by 47% at one of Canada's largest hospitals, Vancouver General Hospital (VGH).